Binding Mode Prediction and Identification of New Lead Compounds from Natural Products as 3-OST Enzyme Inhibitors

(E-pub Ahead of Print)

Author(s): Rui Sousa, NS Hari Narayana Moorthy*, Natercia Bras, Pedro Fernandes, Maria Ramos.

Journal Name: Letters in Drug Design & Discovery

Become EABM
Become Reviewer


Background and Introduction: The availability of antiviral medicines for the treatment of viral diseases is limited, hence it requires to discover novel bioactive molecules. The present investigation has been carried out to develop novel 3-O-sulfotransferase enzyme inhibitors to treat viral diseases.

Method: In this, virtual screening study (QSAR, docking and pharmacophore analysis) and binding mode analysis have been performed on a dataset collected from the literature (synthetic and natural compounds).

Results: The docking studies showed that Glu184, His186, Lys215 and Lys368 residues established the most important hydrogen bonding with several hit compounds. The QSAR results explained that the presence of electronegative atoms/groups in the aromatic or heteroaromatic rings confer increased activity. Furthermore, the flexibility and the aromatic rings with less polar groups have better activity than the compounds connected to purine rings. Finally, the structure-based pharmacophore studies illustrated that the ligand has many polar interaction sites and the projected acceptor and donor groups in the molecules make a significant contribution for the pharmacophore model building.

Conclusion: These studies concluded that the identified two compounds, phomoidride B and Barceloneic acid A, as potential 3-OST inhibitors.

Keywords: 3-OST, HSV-1 infections, Virtual Screening, Heparan Sulfate, QSAR, Pharmacophore

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1570180817666200313105944
Price: $95